Grazax Asthma Prevention

Trial Profile

Grazax Asthma Prevention

Completed
Phase of Trial: Phase III

Latest Information Update: 07 Jul 2017

At a glance

  • Drugs Timothy grass pollen allergen extract (Grastek) (Primary)
  • Indications Allergic rhinoconjunctivitis; Asthma; Grass pollen hypersensitivity
  • Focus Registrational; Therapeutic Use
  • Acronyms GAP
  • Sponsors ALK-Abello
  • Most Recent Events

    • 07 Jul 2017 Results published in an ALK-Abello media release.
    • 30 Jun 2017 According to an ALK-Abello media release, data from the study has been published online in press in The Journal of Allergy and Clinical Immunology.
    • 30 Jun 2017 Results published in an ALK-Abello media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top